---
title: "Nautilus Biotechnology Reports Second Quarter 2026 Financial Results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294065352.md"
description: "On July 28, 2026, Nautilus Biotechnology, Inc. (NASDAQ: NAUT) based in Seattle shared its financial outcomes for the quarter concluding on June 30, 2026. The company specializes in a cutting-edge single-molecule proteome analysis platform."
datetime: "2026-07-28T12:06:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294065352.md)
  - [en](https://longbridge.com/en/news/294065352.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294065352.md)
generator: "portal-rs"
---

# Nautilus Biotechnology Reports Second Quarter 2026 Financial Results

On July 28, 2026, Nautilus Biotechnology, Inc. (NASDAQ: NAUT) based in Seattle shared its financial outcomes for the quarter concluding on June 30, 2026. The company specializes in a cutting-edge single-molecule proteome analysis platform.

### Related Stocks

- [NAUT.US](https://longbridge.com/en/quote/NAUT.US.md)

## Related News & Research

- [Undervalued Penny Stocks To Consider In August 2026](https://longbridge.com/en/news/296816088.md)
- [Enjoei updates financial events calendar for 2026](https://longbridge.com/en/news/297563694.md)
- [Paratus Energy announces Q2 2026 cash dividend of USD 0.22 per share](https://longbridge.com/en/news/297268195.md)
- [AgroGalaxy delays 2025 results release to Nov. 30, 2026](https://longbridge.com/en/news/297440664.md)
- [Systemair corrects dividend record date to Aug. 31, 2026 from Sept. 31 error](https://longbridge.com/en/news/297344953.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**